Mryon R Melamed

Title: Mryon R Melamed: Innovator in Blood Group Antigen Research

Introduction

Mryon R Melamed is a notable inventor based in Dobbs Ferry, NY (US). He has made significant contributions to the field of medical research, particularly in the area of blood group antigens. His innovative work has implications for understanding secretor status and its relation to various health conditions.

Latest Patents

Mryon R Melamed holds a patent for a "Blood group antigen panel." This invention describes a method for determining the secretor status of an individual by analyzing a biological fluid sample. The presence of specific antigens, such as Lewis.sup.a and Lewis.sup.b, indicates whether an individual is a secretor or nonsecretor. Additionally, the invention outlines methods for assessing susceptibility to urogenital infections and distinguishing between urothelial carcinoma and normal tissue. The patent also includes a panel of monoclonal antibodies that are essential for these determinations.

Career Highlights

Mryon R Melamed is affiliated with the Sloan-Kettering Institute for Cancer Research, where he conducts his research. His work has been instrumental in advancing the understanding of blood group antigens and their clinical significance.

Collaborations

Throughout his career, Melamed has collaborated with esteemed colleagues, including Carlos Cordon-Cardo and Kenneth O Lloyd. These partnerships have further enriched his research and contributed to the advancement of cancer research.

Conclusion

Mryon R Melamed's contributions to the field of blood group antigens and secretor status have significant implications for medical research and patient care. His innovative patent and collaborations highlight his commitment to advancing scientific knowledge and improving health outcomes.